Advisory: Cannabidiol (CBD) This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those sold over the counter. Published on 02/01/2023
The State of the Research on Opioid Outcomes Among Lesbian, Gay, Bisexual, Trans... Published on 01/11/2023
DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine WASHINGTON - The U.S. Drug Enforcement Administration is warning the American public... Published on 01/01/2023
Expanding Access to and Use of BHS for People at Risk for or Experiencing Homele... Published on 01/01/2023
Peer Recovery Specialists for Equitable Behavioral Health Among Hispanic and Lat... Published on 01/01/2023
ESPECIALISTAS EN RECUPERACIÓN ENTRE PARES PARA UNA SALUD MENTAL EQUITATIVA ENTRE... Published on 01/01/2023